News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Conference News AHA 2017 Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins Caitlin E. Cox November 14, 2017
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Daily News Statins and Diabetes: Causal Link Reinforced in New Analysis Michael O'Riordan October 25, 2017
News Daily News Black Men Have Twofold Higher Risk of Dying From First CHD Event Michael O'Riordan July 10, 2017
News Conference News SCAI 2017 Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It L.A. McKeown May 19, 2017